Effectiveness and safety of apixaban in over 3.9 million people with atrial fibrillation: a systematic review and meta-analysis
BJR Buckley, DA Lane, P Calvert, J Zhang… - Journal of clinical …, 2022 - mdpi.com
Background: There is a plethora of real-world data on the safety and effectiveness of direct-
acting oral anticoagulants (DOACs); however, study heterogeneity has contributed to …
acting oral anticoagulants (DOACs); however, study heterogeneity has contributed to …
Effectiveness and safety of dabigatran compared to Vitamin K antagonists in non-asian patients with atrial fibrillation: a systematic review and meta-analysis
Abstract Background and Objective Real-life data about the use of dabigatran in patients
with non-valvular atrial fibrillation are warranted. The objective of this systematic review and …
with non-valvular atrial fibrillation are warranted. The objective of this systematic review and …
[HTML][HTML] Patrones y resultados del cambio de anticoagulantes orales directos en la fibrilación auricular no valvular: experiencia en la práctica clínica en España
E Rodilla, MI Orts-Martínez, MÁ Sanz-Caballer… - Revista Clínica …, 2023 - Elsevier
Objetivos El objetivo consistía en evaluar un programa de gestión de anticoagulantes orales
directos (ACOD) en pacientes con fibrilación auricular no valvular (FANV) según sus …
directos (ACOD) en pacientes con fibrilación auricular no valvular (FANV) según sus …
Effectiveness and safety of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: Results of A real-world study in a metropolitan area of northern …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - mdpi.com
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
Effectiveness and safety of oral anticoagulant therapy in a real-world cohort with atrial fibrillation: The SIESTA-A study protocol
MC Montero-Balosa, JA Limón-Mora, A Leal-Atienza… - Plos one, 2023 - journals.plos.org
Introduction Oral anticoagulants (OACs) are first-line drugs for stroke prevention in patients
with atrial fibrillation (AF). The introduction of new lines of therapy with direct oral …
with atrial fibrillation (AF). The introduction of new lines of therapy with direct oral …
Time trends in patient characteristics of new rivaroxaban users with atrial fibrillation in Germany and the Netherlands
A Voss, E Smits, KMA Swart, Y Balabanova… - Drugs-Real World …, 2023 - Springer
Background Use of the direct oral anticoagulant rivaroxaban has strongly increased in
Europe since its market approval for non-valvular atrial fibrillation in 2011. Patients …
Europe since its market approval for non-valvular atrial fibrillation in 2011. Patients …
[HTML][HTML] Patterns and outcomes of switching direct oral anticoagulants in non-valvular atrial fibrillation: A real-world experience from Spain
E Rodilla, MI Orts-Martínez, MA Sanz-Caballer… - Revista Clínica …, 2023 - Elsevier
Aims The aim is to evaluate a management program for direct oral anticoagulants (DOACs)
in non-valvular atrial fibrillation (NVAF) patients according to their profiles, appropriateness …
in non-valvular atrial fibrillation (NVAF) patients according to their profiles, appropriateness …
Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia
M Giner-Soriano, D Ouchi, R Vives… - Frontiers in …, 2023 - frontiersin.org
Objectives: Our objective was to analyse effectiveness and safety of oral anticoagulants
(OAC) for stroke prevention in non-valvular atrial fibrillation. Material and methods …
(OAC) for stroke prevention in non-valvular atrial fibrillation. Material and methods …
Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Real-World Experience from a Single Spanish Regional Hospital
E Rodilla, MI Orts-Martinez, MA Sanz-Caballer… - 2021 - preprints.org
The aim is to evaluate a program for direct oral anticoagulants (DOACs) management in
nonvalvular atrial fibrillation (NVAF) patients, according to patient profiles, appropriateness …
nonvalvular atrial fibrillation (NVAF) patients, according to patient profiles, appropriateness …